Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Banks

Challenger lender Metro Bank paying £596.7mln for a portfolio of UK mortgages, mostly buy-to-let

The FTSE 250-listed firm said the portfolio is primarily made up of buy-to-let mortgages, approximately 92%, with the rest being owner-occupiers

Challenger lender Metro Bank PLC (LON:MTRO) is paying £596.7mln for a portfolio of UK mortgages from a company owned by Cerberus Capital Management.

The FTSE 250-listed firm said the portfolio, bought from Cerberus European Residential Holding, is primarily made up of buy-to-let mortgages, approximately 92%, with the rest being owner-occupiers.

READ: Metro Bank edging closer to having one million customers

It added that all lending in the portfolio is secured on property and has a similar credit risk profile to its current mortgage book.

Metro Bank said the acquisition of the mortgages, being bought at a discount to face value, will be financed using cash from existing resources.

Craig Donaldson, Metro Bank’s chief executive, said: "The acquisition of this high-quality loan Portfolio supports our high-growth, organic business model as we track ever closer to our 2020 guidance."

He added that the acquisition will increase the bank’s loan-to-deposit ratio to about 78%, compared with the 2020 guidance of 80%.

In early morning trading, Metro Bank shares were 1.5%, or 56p higher at 3,775p.

-- Adds share price --

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK